Year 2018 Vol. 26 No 4

GENERAL & SPECIAL SURGERY

M.A. VOYNOV, B.V. MAGNAEV, A.R. ZOTOVA

EFFICIENCY AND EXPEDIENCE OF ANTIBIOTIC TREATMENT FOR COLONIC DIVERTICULITIS

I.M. Sechenov First Moscow State Medical University, Moscow,
The Russian Federation

Objective. To study the efficacy and to establish expedience of antibiotic treatment for diverticulitis.
Methods. The retrospective analysis of 141 medical histories was made of patients with acute uncomplicated diverticulitis, who were treated during the period from 2013 to 2016 years. Antibiotics were prescribed to treat 85 (60.3%) patients (the main group), 56 (39.7%) patients (the control group) were not given antibacterial drugs. To assess the treatment effectiveness, a dynamic assessment of the clinical picture and laboratory indicators was performed. In the long-term period, patients were questioned to determine the nature of the course and the occurrence of relapses of diverticulitis.
Results. The duration of hospitalization of the main group patients was 10.8±3.2 days (M±σ), control - 11.2±2.6 days (M±σ), p>0.05. During the treatment, disease progression was registered in none of the patients. In the main group the body temperature was normalized after 1.6 ± 0.4 days, in the control group after 1.7±0.3 days, p>0.05. The level of leukocytes came back to normal in the main group at 2.7±0.8 days, in the control group at 2.9±0.7 days (p>0.05).
Long-term results were evaluated in 82 (96.5%) of patients and 55 (98.2%) in the control group. Use of antibiotic treatment in diverticulitis had no effect in the remote period for redevelopment of complications (OR 1.19; CI 0.58-2.44), the need to seek medical care (OR 1.11; CI 0.52-2.34), need for hospitalization (OR 0.95, CI 0.3-2.96) and surgical treatment (OR 1.36, CI 0.34-7.69).
Conclusions. The use of antibiotic treatment for diverticulitis does not affect the outcome of treatment and does not determine the further course of the disease. Taking into account the increasing resistance of microorganisms to antibiotics and the need to optimize costs with limited funding for health care, it is advisable to exclude the use of antibacterial drugs for the treatment of uncomplicated diverticulitis.

Keywords: acute uncomplicated diverticulitis, anti-bacterial agents, complications, diverticulitis, treatment of diverticulitis, antibiotic-free treatment
p. 440-446 of the original issue
References
  1. Ivashkin VT, Shelygin IuA, Achkasov SI, Vasil’ev SV, Grigor’ev EG, Dudka VV, Zhukov BN, Karpukhin OIu, Kuz’minov AM, Kulikovskii VF, Lapina TL, Lakhin AV, Maev IV, Moskalev AI, Murav’ev AV, Polovinkin VV, Poluektova EA, Stoiko IuM, Timerbulatov VM, Trukhmanov AS, Frolov SA, Chibisov GI, Shifrin OS, Sheptulin AA, Khalif IL, Efron AG, Ianovoi VV. Rekomendatsii rossiiskoi gastroenterologicheskoi assotsiatsii i assotsiatsii koloproktologov Rossii po diagnostike i lecheniiu vzroslykh bol’nykh divertikuliarnoi bolezn’iu obodochnoi kishki. Ros Zhurn Gastroenterologii Gepatologii Koloproktologii. 2017;26(1):65-80. http://www.gastro-j.ru/files/65_80_1458851709.pdf (in Russ.)
  2. Osadchuk MA, Svistunov AA. Divertikuliarnaia bolezn’ tolstoi kishki: epidemiia 21 veka. Poliklinika. 2014(2):10-16. (in Russ.)
  3. Feingold D, Steele SR, Lee S, Kaiser A, Boushey R, Buie WD, Rafferty JF. Practice parameters for the treatment of sigmoid diverticulitis. Dis Colon Rectum. 2014 Mar;57(3):284-94. doi: 10.1097/DCR.0000000000000075
  4. Nespoli L, Lo Bianco G, Uggeri F, Romano F, Nespoli A, Bernasconi DP, Gianotti L. Effect of oral mesalamine on inflammatory response in acute uncomplicated diverticulitis. World J Gastroenterol. 2015 Jul 21;21(27):8366-72.doi: 10.3748/wjg.v21.i27.8366
  5. Kruse E, Leifeld L. Prevention and conservative therapy of diverticular disease. Chirurg. 2014 Apr;85(4):299-303. doi: 10.1007/s00104-013-2619-4 [Article in German]
  6. Scarpa CR, Buchs NC, Poncet A, Konrad-Mugnier B, Gervaz P, Morel P, Ris F. Short-term intravenous antibiotic treatment in uncomplicated diverticulitis does not increase the risk of recurrence compared to long-term treatment. Ann Coloproctol. 2015 Apr;31(2):52-56. doi: 10.3393/ac.2015.31.2.52
  7. Suarez Alecha J, Amoza Pais S, Batlle Marin X, Oronoz Martinez B, Balen Ribera E, Yarnoz Irazabal C. Safety of nonoperative management after acute diverticulitis. Ann Coloproctol. 2014 Oct;30(5):216-21. doi: 10.3393/ac.2014.30.5.216
  8. Tursi A, Brandimarte G, Elisei W, Picchio M, Forti G, Pianese G, Rodino S, D’Amico T, Sacca N, Portincasa P, Capezzuto E, Lattanzio R, Spadaccini A, Fiorella S, Polimeni F, Polimeni N, Stoppino V, Stoppino G, Giorgetti GM, Aiello F, Danese S. Randomised clinical trial: mesalazine and/or probiotics in maintaining remission of symptomatic uncomplicated diverticular disease–a double-blind, randomised, placebo-controlled study. Aliment Pharmacol Ther. 2013 Oct;38(7):741-51. doi: 10.1111/apt.12463
  9. Gaston-Johansson F. Measurement of pain: the psychometric properties of the Pain-O-Meter, a simple, inexpensive pain assessment tool that could change health care practices. J Pain Symptom Manage. 1996 Sep;12(3):172-81. doi: 10.1016/0885-3924(96)00128-5
  10. Daniels L, ünlü Ñ, de Korte N, van Dieren S, Stockmann HB, Vrouenraets BC, Consten EC, van der Hoeven JA, Eijsbouts QA, Faneyte IF, Bemelman WA, Dijkgraaf MG, Boermeester MA. Randomized clinical trial of observational versus antibiotic treatment for a first episode of CT-proven uncomplicated acute diverticulitis. Br J Surg. 2017 Jan;104(1):52-61. doi: 10.1002/bjs.10309
  11. Unlü C, de Korte N, Daniels L, Consten EC, Cuesta MA, Gerhards MF, van Geloven AA, van der Zaag ES, van der Hoeven JA, Klicks R, Cense HA, Roumen RM, Eijsbouts QA, Lange JF, Fockens P, de Borgie CA, Bemelman WA, Reitsma JB, Stockmann HB, Vrouenraets BC, Boermeester MA. A multicenter randomized clinical trial investigating the cost-effectiveness of treatment strategies with or without antibiotics for uncomplicated acute diverticulitis (DIABOLO trial). BMC Surg. 2010 Jul 20;10:23. doi: 10.1186/1471-2482-10-23
Address for correspondence:
19027, The Russian Federation,
Moscow, Yauzskaya Str., 11/6, b. 1.,
I.M. Sechenov First Moscow
State Medical University,
Department of General Surgery,
Tel.: +7-967-139-36-96,
e-mail: info@doctorvoinov.ru,
Mikhail A. Voinov
Information about the authors:
Voinov Mikhail A., PhD, Assistant of the Department of General Surgery, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation.
http://orcid.org/0000-0001-9857-9249
Magnaev Badma V., Clinical Intern of the Department of General Surgery, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation.
http://orcid.org/0000-0002-7426-7563
Zotova Anna R., Student of the Medical Faculty, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation.
http://orcid.org/0000-0003-4891-279
Contacts | ©Vitebsk State Medical University, 2007-2023